Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
118434613 | 11843461 | 3 | F | 20160908 | 20151217 | 20160909 | EXP | CA-ROCHE-1487796 | ROCHE | 0.00 | F | Y | 70.37000 | KG | 20160909 | CN | CA | CA |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
118434613 | 11843461 | 1 | PS | RITUXAN | RITUXIMAB | 1 | Intravenous (not otherwise specified) | PREVIOUS INFUSION ON 30/APR/2014?PREVIOUS INFUSION ON 29/DEC/2014 | 103705 | 1000 | MG | SOLUTION FOR INFUSION | |||||||
118434613 | 11843461 | 2 | SS | PREDNISONE. | PREDNISONE | 1 | Oral | 0 | QD | ||||||||||
118434613 | 11843461 | 3 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Unknown | U | 0 | ||||||||||
118434613 | 11843461 | 4 | C | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | Oral | 0 | 650 | MG | |||||||||
118434613 | 11843461 | 5 | C | METHYLPREDNISOLON | METHYLPREDNISOLONE | 1 | Intravenous (not otherwise specified) | 0 | 100 | MG | |||||||||
118434613 | 11843461 | 6 | C | RESTASIS | CYCLOSPORINE | 1 | 0 | ||||||||||||
118434613 | 11843461 | 7 | C | LACTULOSE. | LACTULOSE | 1 | 0 | ||||||||||||
118434613 | 11843461 | 8 | C | IVIG | HUMAN IMMUNOGLOBULIN G | 1 | 0 | ||||||||||||
118434613 | 11843461 | 9 | C | MYFORTIC | MYCOPHENOLATE SODIUM | 1 | 0 | ||||||||||||
118434613 | 11843461 | 10 | C | CELLCEPT | MYCOPHENOLATE MOFETILMYCOPHENOLATE MOFETIL HYDROCHLORIDE | 1 | 0 | ||||||||||||
118434613 | 11843461 | 11 | C | DOXYCYCLINE. | DOXYCYCLINE | 1 | Unknown | 0 | 100 | MG | |||||||||
118434613 | 11843461 | 12 | C | PANTOLOC | PANTOPRAZOLE SODIUM | 1 | 0 | ||||||||||||
118434613 | 11843461 | 13 | C | DIPHENHYDRAMINE. | DIPHENHYDRAMINE | 1 | Oral | 0 | 50 | MG |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
118434613 | 11843461 | 1 | Ocular pemphigoid |
118434613 | 11843461 | 2 | Product used for unknown indication |
118434613 | 11843461 | 3 | Product used for unknown indication |
118434613 | 11843461 | 4 | Premedication |
118434613 | 11843461 | 5 | Premedication |
118434613 | 11843461 | 13 | Premedication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
118434613 | 11843461 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
118434613 | 11843461 | Cataract | |
118434613 | 11843461 | Conjunctival scar | |
118434613 | 11843461 | Depression | |
118434613 | 11843461 | Eye inflammation | |
118434613 | 11843461 | Eye pain | |
118434613 | 11843461 | Off label use | |
118434613 | 11843461 | Pain | |
118434613 | 11843461 | Rhinalgia | |
118434613 | 11843461 | Visual acuity reduced | |
118434613 | 11843461 | Weight increased | |
118434613 | 11843461 | White blood cell count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
118434613 | 11843461 | 1 | 20140416 | 0 | ||
118434613 | 11843461 | 4 | 20140416 | 0 | ||
118434613 | 11843461 | 5 | 20140416 | 0 | ||
118434613 | 11843461 | 13 | 20140416 | 0 |